View Author
stent patient lesion trial diabetes mellitus stent thrombosis death spirit thrombosis randomized paclitaxel-eluting diabetes mellitu group paclitaxel-eluting stents study 2- year rates vessel treatment outcome event artery everolimus-eluting revascularization analysis infarction stent type artery lesions table 2 years stent system everolimus-eluting stents target id-tlr everolimu difference paclitaxel-eluting stents jacc safety intervention ischemia-driven xience stone result ef ficacy eluting target lesion revascularization ischemia-driven tlr artery disease ͻ0.0001 restenosi drug-eluting rvd >2.65 mm follow-up ll <13.4 mm ll >13.4 mm signi angiographic diameter abbott research finite syndrome boston scienti fic value patients randomized randomized trials signi ficantly group c interaction system erasmus mc end points spirit ii trial length 2- year mace circulation insulin –15 baseline cohort
